Improving Research to Build a Brighter Future for People with Hematologic Conditions
Individuals living with hematologic conditions need more evidence-based options for managing their health and improving their quality of life. The ASH Research Collaborative™ (ASH RC) is working to accelerate change by making it more efficient to conduct research, from increasing access to high-quality clinical data to making it easier for individuals with hematologic conditions to participate in studies.
Current ASH RC initiatives focus on multiple myeloma and sickle cell disease (SCD) clinical research.
The Data Hub will be the largest shared information resource with real-world data to serve the hematology community. Access to these data can accelerate research and development, support regulatory decision-making, and help clinics identify opportunities for quality improvement. Multiple myeloma and SCD data are now being accepted. Learn about the Data Hub.
The SCD Clinical Trials Network (SCD Network) is fostering collaborative partnerships to accelerate progress in clinical research and improve outcomes for individuals living with SCD by expediting the development of therapeutics and generating high-quality evidence to support clinical decision-making. Learn about the SCD Network.
SCD research progress is impossible without the involvement of the SCD community. Visit the SCD Community page for information just for individuals with SCD, their loved ones, and advocates.